دورية أكاديمية

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al .

التفاصيل البيبلوغرافية
العنوان: Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al .
المؤلفون: Martinez Sanz P; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands p.martinezsanz@sanquin.nl., van Rees DJ; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Matlung HL; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Franke K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.
المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
نوع المنشور: Journal Article; Comment
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: 2020- : London, United Kingdom : BMJ Publishing Group Ltd.
Original Publication: London : BioMed Central, 2013-
مواضيع طبية MeSH: Granulocyte-Macrophage Colony-Stimulating Factor* , Neuroblastoma*/drug therapy, Antibodies, Monoclonal ; Granulocyte Colony-Stimulating Factor ; Humans ; Neutrophils
مستخلص: Competing Interests: Competing interests: None declared.
التعليقات: Comment on: J Immunother Cancer. 2021 Dec;9(12):. (PMID: 34893525)
References: J Immunother Cancer. 2021 May;9(5):. (PMID: 34049929)
Cancer Res. 2015 Sep 15;75(18):3991. (PMID: 26337906)
J Immunother Cancer. 2021 Dec;9(12):. (PMID: 34893525)
Cancer Res. 2013 Jul 1;73(13):4134-46. (PMID: 23687340)
Cancer Res. 2015 Jun 15;75(12):2566-79. (PMID: 25908586)
J Pediatr Surg. 2008 May;43(5):837-42. (PMID: 18485949)
Cancer Res. 1991 Jan 1;51(1):144-9. (PMID: 1988079)
فهرسة مساهمة: Keywords: cytokines; immunotherapy; neuroblastoma
المشرفين على المادة: 0 (Antibodies, Monoclonal)
143011-72-7 (Granulocyte Colony-Stimulating Factor)
7SQY4ZUD30 (dinutuximab)
83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor)
تواريخ الأحداث: Date Created: 20211211 Date Completed: 20211224 Latest Revision: 20211229
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8666886
DOI: 10.1136/jitc-2021-003983
PMID: 34893526
قاعدة البيانات: MEDLINE
الوصف
تدمد:2051-1426
DOI:10.1136/jitc-2021-003983